AAOM clinical practice statement Subject: The use of serum C-terminal telopeptide cross-link of type 1 collagen (CTX) testing in predicting risk of osteonecrosis of the jaw (ONJ)

被引：7
作者：
Bugueno, Juan M. [1 ]
Migliorati, Cesar A. [2 ,3 ]
机构：
[1] Univ Tennessee, Dept Diagnost Sci & Oral Med, Memphis, TN 38152 USA
[2] Univ Florida, Dept Oral & Maxillofacial Diagnost Sci, Coll Dent, Gainesville, FL USA
[3] Univ Florida, Coll Dent, Clin & Qual Assurance, Gainesville, FL USA
来源：
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY | 2017年 / 124卷 / 04期
关键词：
ORAL BISPHOSPHONATES; PREVENTION; OSTEOPOROSIS; ASSOCIATION;
D O I：
10.1016/j.oooo.2017.07.011
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
[No abstract available]
引用
收藏
页码：367 / 368
页数：2
相关论文
共 11 条
  • [1] Baim S, 2009, J BONE MINER RES, V24, P561, DOI [10.1359/jbmr.090203, 10.1359/JBMR.090203]
  • [2] CTX AND ITS ROLE IN MANAGING PATIENTS EXPOSED TO ORAL BISPHOSPHONATES
    Dodson, Thomas B.
    [J]. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2010, 68 (02) : 487 - 488
  • [3] Predicting risk for bisphosphonate-related osteonecrosis of the jaws: CTX versus radiographic markers
    Fleisher, Kenneth E.
    Welch, Garrett
    Kottal, Shailesh
    Craig, Ronald G.
    Saxena, Deepak
    Glickman, Robert S.
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2010, 110 (04): : 509 - 516
  • [4] Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis Executive summary of recommendations from the American Dental Association Council on Scientific Affairs
    Hellstein, John W.
    Adler, Robert A.
    Edwards, Beatrice
    Jacobsen, Peter L.
    Kalmar, John R.
    Koka, Sreenivas
    Migliorati, Cesar A.
    Ristic, Helen
    [J]. JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2011, 142 (11) : 1243 - 1251
  • [5] A C-Terminal Crosslinking Telopeptide Test-Based Protocol for Patients on Oral Bisphosphonates Requiring Extraction: A Prospective Single-Center Controlled Study
    Hutcheson, April
    Cheng, Andrew
    Kunchar, Ranjit
    Stein, Brian
    Sambrook, Paul
    Goss, Alastair
    [J]. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2014, 72 (08) : 1456 - 1462
  • [6] Jade K, 2016, BONE LOSS TEST ALTER
  • [7] Prospective biomarker evaluation in patients with osteonecrosis of the jaw who received bisphosphonates
    Kim, Jin-Woo
    Kong, Kyoung-Ae
    Kim, Sun-Jong
    Choi, Sung-Keun
    Cha, In-Ho
    Kim, Myung-Rae
    [J]. BONE, 2013, 57 (01) : 201 - 205
  • [8] Clinical Investigation of C-Terminal Cross-Linking Telopeptide Test in Prevention and Management of Bisphosphonate-Associated Osteonecrosis of the Jaws
    Kunchur, Ranjit
    Need, Allan
    Hughes, Toby
    Goss, Alastair
    [J]. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2009, 67 (06) : 1167 - 1173
  • [9] Serologic Bone Markers for Predicting Development of Osteonecrosis of the Jaw in Patients Receiving Bisphosphonates
    Lazarovici, Towy Sorel
    Mesilaty-Gross, Shlomit
    Vered, Iris
    Pariente, Clara
    Kanety, Hannah
    Givol, Navot
    Yahalom, Ran
    Taicher, Shlomo
    Yarom, Noam
    [J]. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2010, 68 (09) : 2241 - 2247
  • [10] Oral bisphosphonate-induced osteonecrosis: Risk factors, prediction of risk using serum CTX testing, prevention, and treatment
    Marx, Robert E.
    Cillo, Joseph E., Jr.
    Ulloa, Juan J.
    [J]. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2007, 65 (12) : 2397 - 2410
12